Now showing items 1-5 of 5
Childhood adversity and vulnerability to mood and anxiety disorders
(John Wiley & Sons, Inc., 1997)
Based upon epidemiological surveys, adverse childhood events are proposed to be risk factors for adult depressive and anxiety disorders. However, the extent to which these events are seen in clinical patient populations ...
Pentagastrin infusions in patients with panic disorder II. Neuroendocrinology
(Elsevier, 1994-07-15)
Cholecystokinin (CCK) has well-documented anxiogenic effects in animals and normal people, and panicogenic effects in patients with panic disorder, but little is known about its neuroendocrine profile. We examined ...
Pentagastrin infusions in patients with panic disorder I. Symptoms and cardiovascular responses
(Elsevier, 1994-07-15)
Cholecystokinin (CCK) may mediate human anxiety and animal data suggest that cholecystokinin antagonists could provide an important advance in the treatment of anxiety disorders. The study of CCK receptor systems in ...
Group behavioral therapy of obsessive-compulsive disorder: Seven- vs. twelve-week outcomes
(John Wiley & Sons, Inc., 2001)
Previous research has demonstrated that individualized behavioral exposure and response prevention therapy is an effective treatment for Obsessive-Compulsive Disorder. In our prior preliminary report, 7-week group exposure ...